MAPKAPK2 (Ab-272) Antibody

What is MAPKAPK2 and what is its role in cellular signaling pathways?

MAPKAPK2 (mitogen-activated protein kinase-activated protein kinase 2), also known as MK2, is a direct substrate of p38 MAPK and belongs to the CAMK Ser/Thr protein kinase family. It functions as a master regulator of RNA-binding proteins (RBPs) and plays crucial roles in:

• Post-transcriptional regulation of genes containing adenine/uridine-rich elements (AREs) in their 3'-UTR

• Inflammatory responses through regulation of cytokine production (TNFα, IL-1β, IL-8, IL-6)

• Cell-cycle control at CDC25- and p53-dependent checkpoints

• Stress response signaling

The protein has a calculated molecular weight of 46 kDa but is typically observed at 47-50 kDa on Western blots due to post-translational modifications .

What epitope does the MAPKAPK2 (Ab-272) antibody recognize?

The MAPKAPK2 (Ab-272) antibody is generated against a synthetic non-phosphopeptide derived from human MAPKAPK2 around the phosphorylation site of serine 272 (A-I-S(p)-P-G). This antibody specifically recognizes endogenous levels of total MAPKAPK2 protein regardless of its phosphorylation status at Ser272 .

What applications has the MAPKAPK2 (Ab-272) antibody been validated for?

The MAPKAPK2 (Ab-272) antibody has been validated for multiple experimental applications:

The antibody has been cited in multiple publications for WB and IHC applications, demonstrating its reliability in peer-reviewed research .

How does phosphorylation at Ser272 affect MAPKAPK2 function and detection?

Ser272 is one of four key phosphorylation sites (along with Thr25, Thr222, and Thr334) that regulate MAPKAPK2 activity. The phosphorylation at Thr222, Ser272, and Thr334 is essential for the full activation of MAPKAPK2. While the MAPKAPK2 (Ab-272) antibody recognizes the region around Ser272, it detects the total protein regardless of phosphorylation status .

For functional studies:

• Phosphorylation at Ser272 by p38 MAPK occurs in response to cellular stress and inflammatory stimuli

• This phosphorylation contributes to a conformational change that activates MAPKAPK2

• To study specifically phosphorylated forms, phospho-specific antibodies would be required instead of the Ab-272 antibody

When interpreting results, researchers should consider that cellular stress conditions may alter the phosphorylation state and potentially the migration pattern of MAPKAPK2 on Western blots (47-49 kDa for phosphorylated form) .

What approaches can distinguish between MAPKAPK2 and closely related kinases (MK3, MK5)?

Distinguishing between closely related MAPKAPK family members requires careful experimental design:

• Antibody specificity validation:

  • The MAPKAPK2 (Ab-272) antibody has been designed against a specific sequence around Ser272 that differs from homologous regions in MK3 and MK5

  • Validate specificity using knockout/knockdown controls for each kinase

• Molecular weight discrimination:

  • MAPKAPK2: 46-50 kDa

  • MK3: 42-43 kDa

  • MK5: 54-56 kDa

• Expression pattern analysis:

  • MAPKAPK2 shows high expression in immune cells and is responsive to LPS stimulation

  • Different cell types express varying levels of each kinase

• Functional validation:

  • Using selective inhibitors: MK2 inhibitor III has differential potency (IC₅₀ of 8.5 nM for MK2 versus 81 nM for MK3 and 210 nM for MK5)

  • Substrate specificity analysis

When publishing results, explicitly address potential cross-reactivity with related kinases to strengthen the validity of your findings.

What sample preparation methods are recommended for optimal MAPKAPK2 detection?

For optimal detection of MAPKAPK2 using the Ab-272 antibody, consider these sample preparation guidelines:

For Western Blotting:

• Extract proteins using buffers containing protease inhibitors and phosphatase inhibitors (essential for preserving phosphorylation states)

• Recommended lysis buffer: RIPA or NP-40 buffer with 1mM PMSF, 10mM NaF, 1mM Na₃VO₄

• Heat samples at 95°C for 5 minutes in reducing sample buffer

• Load 20-50μg of total protein per lane

For Immunohistochemistry:

• Formalin-fixed paraffin-embedded (FFPE) tissue sections (5μm thickness)

• Antigen retrieval using TE buffer pH 9.0 (recommended) or alternatively citrate buffer pH 6.0

• Blocking with 5% normal goat serum in PBS for 1 hour at room temperature

For Immunofluorescence:

• Fix cells with 4% paraformaldehyde for 15 minutes at room temperature

• Permeabilize with 0.2% Triton X-100 in PBS for 5 minutes

• Block with 3% BSA in PBS for 1 hour

How should I optimize antibody dilution and minimize background signal?

Optimizing antibody dilution is critical for specific MAPKAPK2 detection:

• Titration approach:

  • Start with the manufacturer's recommended range (WB: 1:500-1:2500, IHC: 1:50-1:500, IF: 1:200-1:800)

  • Perform a dilution series (e.g., 1:500, 1:1000, 1:2000 for WB)

  • Evaluate signal-to-noise ratio at each dilution

• Blocking optimization:

  • For WB: 5% non-fat dry milk or 5% BSA in TBST (use BSA for phospho-detection)

  • For IHC/IF: 3-5% serum from the same species as the secondary antibody

• Washing steps:

  • Increase washing duration and number of washes (at least 3×5 minutes with TBST)

  • Use gentle agitation during washes

• Secondary antibody considerations:

  • Match host species (anti-rabbit for this antibody)

  • Optimize dilution separately from primary antibody

  • Consider using highly cross-adsorbed versions to reduce non-specific binding

For fluorescently conjugated versions (AF488, AF555, AF647, etc.), additional optimization may be needed to balance signal intensity and photobleaching.

How do I interpret multiple bands when using MAPKAPK2 (Ab-272) antibody in Western blotting?

When multiple bands appear on Western blots using the MAPKAPK2 (Ab-272) antibody, consider these interpretations:

• Expected MAPKAPK2 bands:

  • Main band at 46-47 kDa (unphosphorylated)

  • Higher molecular weight band at 49-50 kDa (phosphorylated form)

  • These mobility shifts are normal and indicate activation status

• Common causes of additional bands:

  • Isoforms: MAPKAPK2 has multiple isoforms generated through alternative splicing

  • Degradation products: Ensure complete protease inhibition during sample preparation

  • Post-translational modifications: Phosphorylation can cause mobility shifts

  • Cross-reactivity: Particularly with MAPKAPK3 (MK3) in some tissues

• Validation approaches:

  • Compare with positive control lysates (e.g., LPS-stimulated macrophages)

  • Use MAPKAPK2 knockout/knockdown samples as negative controls

  • Analyze band pattern changes after treatments known to activate p38-MAPKAPK2 pathway

  • Peptide competition assay using the immunizing peptide

When reporting results with multiple bands, clearly state which band(s) you are analyzing and provide justification based on molecular weight and expected modification state.

What are common troubleshooting strategies for weak or no signal detection?

When experiencing detection issues with MAPKAPK2 (Ab-272) antibody:

• Weak or no signal:

  • Increase antibody concentration gradually (within recommended range)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Enhance detection sensitivity with amplification systems (biotin-streptavidin)

  • Increase protein loading (up to 50-80μg per lane)

  • Verify target protein expression in chosen samples

  • For IHC/IF, optimize antigen retrieval conditions

• High background:

  • Increase blocking time and concentration

  • Reduce primary antibody concentration

  • Add 0.1% Tween-20 to antibody diluent

  • Increase number and duration of washes

  • Filter blocking solutions to remove particulates

  • Ensure secondary antibody compatibility and dilution

• Non-specific bands:

  • Increase blocking stringency

  • Ensure fresh samples with proper protease inhibition

  • Optimize SDS-PAGE conditions (percentage, running time)

  • Increase wash stringency with higher salt concentration

• Tissue-specific optimization:

  • Different tissues may require specific fixation/permeabilization protocols

  • Endogenous peroxidase/biotin blocking for IHC

  • Autofluorescence quenching for IF in certain tissues

Document all optimization steps for reproducibility across experiments and consider publishing these details in methods sections.

How can I use MAPKAPK2 (Ab-272) antibody to study stress response pathways?

The MAPKAPK2 antibody can be effectively employed to investigate stress response pathways:

• Activation kinetics analysis:

  • Time-course experiments following stress induction (UV, heat shock, oxidative stress)

  • Dual staining with phospho-specific antibodies to correlate MAPKAPK2 activation with phosphorylation

  • Western blot analysis showing mobility shift from 46 kDa to 49 kDa upon activation

• Subcellular localization studies:

  • Immunofluorescence to track nuclear-cytoplasmic shuttling following stress

  • Co-localization with p38 MAPK and downstream targets

  • Live-cell imaging using GFP-tagged MAPKAPK2 complemented with antibody validation

• Pathway inhibition studies:

  • Compare effects of p38 MAPK inhibitors versus direct MK2 inhibitors

  • Analyze downstream target phosphorylation (Hsp27, hnRNP A0, TTP)

  • Correlate with stress granule formation and RNA-binding protein interactions

• Quantitative applications:

  • Use conjugated antibodies for flow cytometry to measure cellular MAPKAPK2 levels

  • Develop ELISA assays using MAPKAPK2 (Ab-272) as capture antibody

  • ChIP assays to identify genomic targets of MAPKAPK2-regulated transcription factors

Stress response experiments should always include physiologically relevant stressors and appropriate time points based on the cell type under investigation.

What experimental approaches can link MAPKAPK2 to RNA-binding protein regulation?

MAPKAPK2 functions as a master regulator of RNA-binding proteins. To study this relationship:

• RBP phosphorylation analysis:

  • Immunoprecipitate MAPKAPK2 using Ab-272 followed by in vitro kinase assays

  • Western blot analysis of RBP phosphorylation states (TTP, hnRNP A0, PABP1)

  • Phospho-specific antibodies against known MAPKAPK2 substrate sites on RBPs

• mRNA stability assays:

  • Actinomycin D chase experiments with/without MAPKAPK2 inhibition

  • qRT-PCR analysis of ARE-containing transcripts (TNFα, IL-1β, IL-6, IL-8)

  • Northern blot analysis of transcript half-lives

• RNA-protein interaction studies:

  • RNA immunoprecipitation (RIP) assays following MAPKAPK2 activation

  • Cross-linking immunoprecipitation (CLIP) analysis

  • Biotinylated RNA pull-down assays with/without MAPKAPK2 inhibition or activation

• Functional correlation:

  • Cytokine production assays correlated with MAPKAPK2 activation

  • Polysome profiling to assess translation efficiency

  • Stress granule formation analysis by immunofluorescence

These approaches should combine the Ab-272 antibody with other molecular tools to establish causal relationships between MAPKAPK2 activation and RBP-mediated regulation of target transcripts .

How can MAPKAPK2 (Ab-272) antibody be used in single-cell analysis techniques?

Emerging single-cell technologies can benefit from MAPKAPK2 antibody applications:

• Single-cell imaging:

  • Immunofluorescence using conjugated MAPKAPK2 (Ab-272) antibodies (AF488, AF555, AF647)

  • Quantitative image analysis of protein expression heterogeneity

  • High-content screening approaches following stimulation or drug treatment

• Mass cytometry (CyTOF):

  • Metal-conjugated MAPKAPK2 antibodies for multiparameter analysis

  • Correlation with phospho-specific markers of the p38 MAPK pathway

  • Heterogeneity analysis across cell populations

• Single-cell western blotting:

  • Microfluidic-based protein analysis using optimized antibody dilutions

  • Correlating MAPKAPK2 levels with activation states in rare cell populations

• Spatial proteomics:

  • Multiplex immunofluorescence using MAPKAPK2 (Ab-272) with organelle markers

  • Tissue-based spatial analysis of MAPKAPK2 distribution

These emerging techniques require careful optimization of antibody concentration, incubation time, and signal amplification strategies appropriate for the sensitivity requirements of single-cell detection .

What are the considerations for using MAPKAPK2 (Ab-272) antibody in translational research models?

When applying MAPKAPK2 antibody in translational research contexts:

• Disease model validation:

  • Verify antibody reactivity in disease-relevant tissues

  • Optimize protocols for diseased tissues which may have altered protein expression

  • Include proper controls specific to the pathological condition

• Biomarker potential assessment:

  • Standardize detection protocols for consistent quantification

  • Establish normal ranges of MAPKAPK2 expression in relevant tissues

  • Correlate with clinical parameters and disease progression

• Therapeutic target validation:

  • Use in parallel with MK2 inhibitors to confirm target engagement

  • Monitor both total MAPKAPK2 (using Ab-272) and phospho-MAPKAPK2 levels

  • Assess activation status in response to therapeutic interventions

• Species cross-reactivity considerations:

  • Validated for human and mouse samples (important for preclinical models)

  • May require additional validation for other experimental animal models

  • Consider sequence homology at the epitope region when using in non-validated species